Hcw biologics is granted third fundamental patent: u.s. patent for methods of treating age-related disorders

Allowed methods of use claims directed to administering hcw9218 to treat cancer, including killing or reducing the number of senescent cells in subjects with cancer allowed methods of use claims directed to administering hcw9218 to treat cancer, including killing or reducing the number of senescent cells in subjects with cancer
HCWB Ratings Summary
HCWB Quant Ranking